Research Portfolio

We invite you to learn about the Foundation's research grants. The search feature and the table below represent the Foundation's complete research portfolio. You may search the complete list of grants by status (open/active or closed/inactive), research program area, and disease.

If you are interested in a specific research program area, browse the recently funded research by program area.

To browse active grants you may also wish to view the 2020 Grants Portfolio publication.

Filter for Grant pages

Research Program Area
Grant Status:

Keyword Search for Grant pages

Search Results





Research Program Area

02534: Clinical Trial for Evaluation of Propranolol and Doxorubicin in the Treatment of Canine Hemangiosarcoma University of Minnesota Erin B. Dickerson, PhD and Brian Husbands, DVM Open Oncology - Hemangiosarcoma
02643-A: Examination of the Effects of Cannabidiol on Canine Neoplastic Cell Apoptosis/Autophagy and Potential for Chemotherapy Resistance or Sensitivity Cornell University Joseph J. Wakshlag, DVM, PhD Open Oncology
02595-A: Defining the Flow Cytometric Characteristics of Normal and Diseased Canine Spleen and Visceral Lymph Nodes University of Minnesota Courtney E. Johnson, DVM Open Oncology
02636-A: Development of RNA in-situ Hybridization to Identify T Regulatory Cells and their Function within the Tumor Microenvironment of Canine Oral Malignant Melanoma University of Florida Sandra M. Bechtel, DVM Open Oncology
02663: Comparative Brain Tumor Consortium (CBTC) Meningioma Pathology Board National Institutes of Health/National Cancer Institute/Center for Cancer Research/Comparative Oncology Program, Cornell University, and University of Pennsylvania Amy LeBlanc, DVM, Andrew Miller, DVM and Molly Church, MS, VMD, PhD Open Oncology
02642-A: NF-kappaB Inactivation Enhances Apoptosis in Canine Osteosarcoma Cells University of Georgia Travis Laver, VMD, PhD Open Oncology - Osteosarcoma
02487: OX40 Checkpoint Molecule Targeted Antibodies for Cancer Immunotherapy in Dogs Colorado State University Steven W. Dow, DVM, PhD Open Oncology
02510-T: Identification of Novel Synthetic Lethal Partners to Optimize PI3K Targeted Therapies in Canine Hemangiosarcoma Tufts University School of Medicine Cheryl A. London, DVM, PhD Open Oncology - Hemangiosarcoma
2489: Tumor-permissive Collagen Signatures in Canine Mammary Gland Tumors: Development of Prognostic Markers and Targeted Therapies for Improved Outcomes University of Pennsylvania Susan W. Volk, VMD, PhD Open Oncology
02522-A: The Investigation of Lypoxigenase-5 Expression in Canine Normal, Hyperplastic and Neoplastic Urinary Bladder Epithelium University of Liverpool Riccardo Finotello, DVM, PhD Closed Oncology
02502: Precision Medicine for Canine Lymphoma Trustees of the University of Pennsylvania Nicola J Mason, BVetMed, PhD Open Oncology - Lymphoma
02519: Prevalence of Bartonella spp. Infection in Dogs with Cardiac and Splenic Hemangiosarcomas within and between Geographic Locations North Carolina State University Edward B Breitschwerdt, DVM; Matthew Breen, PhD Open Oncology - Hemangiosarcoma
02500: Immune Targeting of the V600E B-Raf Neoantigen in Canine Urothelial Carcinoma University of Pennsylvania Nicola J Mason, BVetMed, PhD Open Oncology
02456-A: The Impact of Intravenous Anesthetic Agents on Canine Natural Killer Cell Trustees of the University of Pennsylvania Oliver A Garden, BVetMed, PhD Open Oncology
02455-A: Identification of genetic mutations in anal sac carcinoma in English Cocker Spaniels University of Georgia Shaying Zhao, PhD Closed Oncology
02405-A: Transcriptome Based Diagnostics in Canine Soft Tissue Sarcoma Cornell University Andrew D. Miller, DVM Closed Oncology
02321: Clinical Trial of Procaspase-3 Activator (PAC-1) in Combination with Hydroxyurea for Treatment of Canine Meningioma University of Illinois Timothy M. Fan, DVM, PhD Open Oncology
02316: Genetic Risk Factors for Canine T zone Lymphoma Colorado State University Anne A. Avery, DVM, PhD Open Oncology - Lymphoma
02317: The Role of Complex Translocations Associated with TP53 Somatic Mutations for Aiding Prognosis of Canine Diffuse Large B cell Lymphoma North Carolina State University Matthew Breen, PhD Open Oncology - Lymphoma
2309-T: Targeting the Cancer Epigenome: The Effect of Specific Histone Lysine Methyltransferase Inhibition in Canine B-Cell Lymphoma University of Missouri Angela McCleary-Wheeler, DVM, PhD Open Oncology - Lymphoma
02318: Genetic and Environmental Risk for Lymphoma in Boxer Dogs University of Wisconsin, Madison Lauren A. Trepanier, DVM, PhD Closed Oncology - Lymphoma
02304-A: Investigating a Biomarker and Novel Therapeutic Target for Canine Diffuse Large B Cell Lymphoma North Carolina State University Jennifer A. Luff, VMD, PhD Closed Oncology - Lymphoma
02315-A: Discovering Peptide Targets for Development of Adoptive Cell Therapy for Peripheral T-Cell Lymphoma North Carolina State University Paul R. Hess, DVM, PhD Closed Oncology - Lymphoma
02234-MOU: A Novel Approach for Prevention of Canine Hemangiosarcoma University of Minnesota Jaime F Modiano, VMD, PhD Open Oncology - Hemangiosarcoma
02215: A Cancer Vaccine for Canine Osteosarcoma University of Florida Rowan J Milner, BVSc Closed Oncology, Oncology - Osteosarcoma
02237-A: Capturing Tumor Cells in Canine Blood Cornell University Tracy Stokol, PhD Closed Oncology
02204-T: Using Enhanced Imaging to Evaluate Tumor Margins for Canine Mammary Cancer and Soft Tissue Sarcoma Ohio State University Laura E. Selmic, BVetMed Closed Oncology
2217: A Novel Mechanism to Regulate the Growth of Canine Hemangiosarcoma University of Minnesota Erin B. Dickerson, PhD Closed Oncology, Oncology - Hemangiosarcoma
02171-MOU: Histiocytic Sarcoma in Bernese Mountain Dogs: Novel Approaches To Treatment Michigan State University Vilma Yuzbasiyan-Gurkan, PhD Closed Oncology
02093-A: Sequencing Histiocytic Sarcoma (HS) loci identified by Genetic Association studies in the Bernese Mountain Dog (BMD) CNRS - University of Rennes Catherine Andre, PhD Closed Oncology
02091-A: Differentiating between Localized and Disseminated Histiocytic Sarcoma in Bernese Mountain Dogs National Human Genome Research Institute Elaine A Ostrander, PhD Closed Oncology
01949-A: Targeting the Cell's Activation Machinery to Halt Tumor Metastasis in Canine Osteosarcoma Oregon State University Shay Bracha, DVM, MS Closed Oncology - Osteosarcoma
02071: Development of a Therapeutic Brain Tumor Vaccine University of Minnesota Grace Elizabeth Pluhar, DVM, PhD Closed Oncology
01889-G: Innovations in Prevention, Diagnosis, and Treatment of Cancer - Goldens Lead the Way University of Minnesota Jaime F Modiano, VMD, PhD Closed Oncology
02092-A: Developing the Use of a Novel Imaging Technique to Define a Dog's Potential Responsiveness to Chemotherapy Purdue University Michael O. Childress, DVM, MS Closed Oncology - Lymphoma
02081-A: Integrating Cutting Edge Science with Scientific Training to Defeat Hemangiosarcoma University of Minnesota Jaime F Modiano, VMD, PhD Closed Oncology - Hemangiosarcoma
01918-G: Discovery of Biomarkers to Detect Lymphoma Risk, Classify For Treatment, and Predict Outcome in Golden Retrievers University of Missouri, Columbia Jeffrey N. Bryan, DVM Closed Oncology - Lymphoma
01929-A: Arginine Dependence: Identification of Cancer's Achilles Heel University of California, Davis Carlos O. Rodriguez Jr, DVM, PhD Closed Oncology
01925-A: Discovery of Novel Micro-Ribonucleic Acids for Diagnosis and Prognosis of Canine Hemangiosarcoma Auburn University Bruce F Smith, VMD, PhD Closed Oncology - Hemangiosarcoma
1806: A Novel Virus-Based Anti-Tumor Treatment for Canine Osteosarcoma Auburn University Bruce F Smith, VMD, PhD Closed Oncology - Osteosarcoma
01914-A: Defining the Genes That Contribute to the Development of Soft Tissue Sarcomas University of Utrecht Kim Miranda Boerkamp, DVM Closed Oncology
01903-A: Defining the Anti-Tumor Activity of Monocytes in Osteosarcoma North Carolina State University Duncan Lascelles, PhD Closed Oncology - Osteosarcoma
01911-A: Enhanced Hemangiosarcoma Therapy Using a Novel Combination of Drugs That Target Tumor Proliferation Van Andel Research Institute Nicholas S. Duesbery, PhD Closed Oncology - Hemangiosarcoma
01912-A: Enhancing the Safety and Efficacy of Anti-Cancer Drugs in Dogs Research Foundation of State University of New York Javier G. Blanco, PhD Closed Oncology
01822: Beyond the Genome: The Intersection of Genes and the Environment in Canine Cancer University of California, Los Angeles Robert K Wayne, PhD Closed Oncology
01826: A Novel Treatment for Brain Tumors Using a One Medicine Approach University of Georgia Simon R. Platt, BVMS Closed Oncology
1787: Clinical Advancement of a Cancer Vaccine in Dogs University of Pennsylvania Nicola J Mason, BVetMed, PhD Closed Oncology - Lymphoma
01759: Disrupting the Differentiation of Cancer Stem Cells to Prevent the Spread of Hemangiosarcoma University of Minnesota Jaime F Modiano, VMD, PhD Closed Oncology - Hemangiosarcoma
01843: Further Investigation of the Genes Controlling Canine Leukemia to Properly Diagnose and Control the Disease North Carolina State University Matthew Breen, PhD Closed Oncology
01876-A: Ensuring That Emerging Stem Cell Treatments Do Not Activate or Exacerbate Cancer in Dogs Colorado State University Douglas H Thamm, VMD Closed Oncology

Help Future Generations of Dogs

Participate in canine health research by providing samples or by enrolling in a clinical trial. Samples are needed from healthy dogs and dogs affected by specific diseases.

Learn How to Help

Connect With Us:
Get Canine Health News:
Please leave this field empty

© 2018 AKC Canine Health Foundation | Privacy Policy | Site Map

Site by Blackbaud, Inc.

Powered by Blackbaud
nonprofit software